Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,839 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Author Correction: Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine.
Kavanagh ME, Horning BD, Khattri R, Roy N, Lu JP, Whitby LR, Ye E, Brannon JC, Parker A, Chick JM, Eissler CL, Wong AJ, Rodriguez JL, Rodiles S, Masuda K, Teijaro JR, Simon GM, Patricelli MP, Cravatt BF. Kavanagh ME, et al. Among authors: roy n. Nat Chem Biol. 2022 Nov;18(11):1288. doi: 10.1038/s41589-022-01181-6. Nat Chem Biol. 2022. PMID: 36180594 No abstract available.
Selective inhibitors of JAK1 targeting an isoform-restricted allosteric cysteine.
Kavanagh ME, Horning BD, Khattri R, Roy N, Lu JP, Whitby LR, Ye E, Brannon JC, Parker A, Chick JM, Eissler CL, Wong AJ, Rodriguez JL, Rodiles S, Masuda K, Teijaro JR, Simon GM, Patricelli MP, Cravatt BF. Kavanagh ME, et al. Among authors: roy n. Nat Chem Biol. 2022 Dec;18(12):1388-1398. doi: 10.1038/s41589-022-01098-0. Epub 2022 Sep 12. Nat Chem Biol. 2022. PMID: 36097295 Free PMC article.
Blood-based quantification of Aβ oligomers indicates impaired clearance from brain in ApoE ε4 positive subjects.
Blömeke L, Rehn F, Pils M, Kraemer-Schulien V, Cousin A, Kutzsche J, Bujnicki T, Freiesleben SD, Schneider LS, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Hansen N, Rostamzadeh A, Düzel E, Glanz W, Incesoy EI, Buerger K, Janowitz D, Ewers M, Perneczky R, Rauchmann BS, Teipel S, Kilimann I, Laske C, Munk MH, Spottke A, Roy N, Heneka MT, Brosseron F, Wagner M, Roeske S, Ramirez A, Schmid M, Jessen F, Bannach O, Peters O, Willbold D. Blömeke L, et al. Among authors: roy n. Commun Med (Lond). 2024 Dec 10;4(1):262. doi: 10.1038/s43856-024-00690-w. Commun Med (Lond). 2024. PMID: 39658587
Prevalence and patterns of testing for anaemia in primary care in England.
Smith M, Wright-Drakesmith C, Haynes S, Maynard S, Shah A, Roy NB, Lee J, Maurer K, Stanworth SJ, Bankhead C. Smith M, et al. Among authors: roy nb. Br J Gen Pract. 2024 Dec 10:BJGP.2024.0336. doi: 10.3399/BJGP.2024.0336. Online ahead of print. Br J Gen Pract. 2024. PMID: 39658076
PreVenTB trial: protocol for evaluation of efficacy and safety of two vaccines VPM1002 and Immuvac (Mw) in preventing tuberculosis (TB) in healthy household contacts of newly diagnosed sputum smear-positive pulmonary TB patients: phase III, randomised, double-blind, three-arm placebo-controlled trial.
Singh M, Mehendale S, Guleria R, Sarin R, Tripathy S, Gangakhedkar RR, Katoch K, Pandey RM, Panda S, Pati S, Mohapatra PR, Joshi S, Narasimhaiah S, Kodan P, Bhaskar S, Rani R, Khan AM, Swaminathan S; PreVenTB Trial Team. Singh M, et al. BMJ Open. 2024 Aug 31;14(8):e082916. doi: 10.1136/bmjopen-2023-082916. BMJ Open. 2024. PMID: 39645271 Free article. Clinical Trial.
1,839 results